Photopharmics kickstarts phototherapy trial for Parkinson’s disease
The Celeste phototherapy device uses light to treat symptoms in Parkinson’s patients linked to the circadian system.
The Celeste phototherapy device uses light to treat symptoms in Parkinson’s patients linked to the circadian system.
In the trial, mRNA-1283 elicited a higher immune response against the SARS-CoV-2 virus, compared to mRNA-1273.222.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Gedeon Richter adopts TransPerfect’s trial management solutions
Artificial intelligence identified two evolutionary pathways of prostate cancer
BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment
Psychedelic treatments for mental health: Is there substance behind the hype?